D. Boral Capital Reaffirms Buy Rating for Coya Therapeutics (NASDAQ:COYA)
Coya Therapeutics (NASDAQ:COYA – Get Free Report)‘s stock had its “buy” rating reiterated by stock analysts at D. Boral Capital in a research report issued on Tuesday,Benzinga reports. They currently ...
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Receives $6.63 Average Price Target from Analysts
Shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA – Get Free Report) have been assigned an average recommendation of “Buy” ...
bovnews18h
Dyne Therapeutics Inc (DYN) Stock Price Reaches $14.55: What Factors Are Influencing This Level?
Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and ...
UBX stock touches 52-week high at $2.02 amid market optimism
Unity Biotechnology Inc (NASDAQ:UBX) stock has reached a 52-week high, trading at $2.02, signaling a period of robust ...